Superoxide dismutase and catalase significantly improve the osteogenic differentiation potential of osteogenetically compromised human adipose tissue-derived stromal cells in vitro.
Sahlender B., Windolf J., Suschek CV.
Laboratory Study, published in Stem Cell Res (2022) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Stem Cell Res (2022)
- Country
- England
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 35180586
- DOI
- 10.1016/j.scr.2022.102708
Abstract (original English)
Mesenchymal stromal cells (MSCs) play a pivotal role in modern therapeutic approaches of bone defect regeneration. A complication that is steadily increasing due to demographic population developments is an age-related disorder of the osteogenic differentiation potential (ODP) of MSCs. In the present in vitro study we have evaluated the impact of reactive oxygen species (ROS) and antioxidants on ODP of "normal healthy" as well as osteogenetically compromised human adipose tissue-derived stromal cells (ASC). We show that although ASC exhibit a marked ODP, a significant number of ASC cultures showed a retarded osteogenesis. These so-called "non-responder"-ASC cultures (NR-ASC) expressed an antigenic phenotype identical to that of the well osteogenically differentiating "responder"-ASCs (R-ASC), but NR-ASC significantly correlated with the older age of their donors as well as with a significantly higher intracellular generation of ROS. Furthermore, we found that treatment of the cell cultures with low concentration of H 2 O 2 seemed to promote osteogenic differentiation but higher H 2 O 2 concentration strongly reduced osteogenesis in all ASC cultures. Additionally, we found that exogenously applied superoxide dismutase (SOD) or catalase completely restored the impaired ODP of NR-ASC, whereas ascorbate, glutathione, N-acetylcysteine or a water soluble vitamin E derivate did not sh
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.